fashion -WSS

fashion

author：knowledge 2025-09-28 21:58:10 - browse：36

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Surge of respiratory disease in China has likely explanation

WSS

Poor hospice wound care hurts patients and families

Ransomware attacks on hospitals: Study outlines patient impact

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Why medical students are struggling with mental health

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Childhood cancer progress stalls for Black, Hispanic kids: Report

entertainment

fashion

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

White House announces new plan to address the growing threat of xylazine in overdose crisis

Guidelines to prevent youth baseball injuries need more muscle

Anthos stroke drug appears safer than common blood thinner

State Dept. review finds Biden bears some blame for Afghanistan failures

Wisconsin governor employs partial veto to fund schools for 4 centuries

Tori Bowie and the unacceptable rates of Black maternal death

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Peter Hotez and the public health issue of online harassment

The aspartame in Diet Coke probably isn’t giving you cancer

focus

Childhood cancer progress stalls for Black, Hispanic kids: Report

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Surge of respiratory disease in China has likely explanation

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Surge of respiratory disease in China has likely explanation

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

entertainment

knowledge

entertainment

knowledge